基于CBCT合成CT的鼻咽癌自适应放疗:深度学习自动分割精度与剂量计算一致性
本研究回顾性分析16例接受两阶段离线自适应放疗的鼻咽癌患者,利用cycle-GAN从每周CBCT生成合成CT,评估深度学习自动分割精度与GPU加速蒙特卡洛剂量重算的一致性。多数解剖结构DSC>0.85、HD95<5.10 mm,但GTVn分割一致性较低(DSC 0.43),部分剂量参数差异有统计学意义,腮腺解剖变化与离线自适应计划调整显著相关。
要点
- 多数结构自动分割精度较高,DSC>0.85且HD95<5.10 mm。
- GTVn分割一致性较低(DSC 0.43,HD95 16.42 mm),需人工复核。
- 腮腺解剖变化与离线自适应计划调整显著相关(ρ>0.72)。
核心结论
- 该方法在体积和剂量参数上与既往治疗数据差异较小,有望通过减少人工依赖提升鼻咽癌自适应放疗效率。
研究设计与样本
- 回顾性分析16例接受两阶段离线自适应放疗的鼻咽癌患者,以pCT1和pCT2为金标准,结合每周CBCT。
- 使用独立数据集训练的cycle-GAN从CBCT生成合成CT(sCT1、sCT4、sCT4*),在sCT上自动分割并行GPU加速蒙特卡洛剂量重算。
- 采用DSC和HD95评估自动分割精度,通过剂量体积参数评估sCT剂量计算保真度,并用Spearman相关分析剂量一致性。
主要发现
- 多数解剖结构pCT-sCT一致性较高,平均DSC>0.85、HD95<5.10 mm。
- pCT2-sCT4比较中GTVp的DSC为0.75、HD95为6.03 mm;GTVn的DSC为0.43、HD95为16.42 mm;颌下腺DSC为0.64-0.73、HD95为4.45-5.66 mm。
- 剂量学分析显示GTVn D99平均差异为-1.44 Gy(95% CI:[-3.01, 0.13] Gy),右腮腺平均剂量差异为-1.94 Gy(95% CI:[-3.33, -0.55] Gy,p<0.05)。
- sCT测量的解剖变化与离线自适应计划调整显著相关,腮腺相关性强(ρ>0.72,p<0.001),与sCT剂量差异分析一致(ρ>0.57,p<0.05)。
临床怎么用
- 对GTVn和颌下腺等一致性较低的结构,自动分割结果需人工复核后再用于自适应放疗。
- 可利用sCT评估腮腺等结构的解剖变化,辅助判断离线自适应计划调整的必要性。
局限性
- 本研究为回顾性分析,样本量16例,结论需更大队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate the precision of automated segmentation facilitated by deep learning (DL) and dose calculation in adaptive radiotherapy (ART) for nasopharyngeal cancer (NPC), leveraging synthetic CT (sCT) images derived from cone-beam CT (CBCT) scans on a conventional C-arm linac. MATERIALS AND METHODS: Sixteen NPC patients undergoing a two-phase offline ART were analyzed retrospectively. The initial (pCT1) and adaptive (pCT2) CT scans served as gold standard alongside weekly acquired CBCT scans. Patient data, including manually delineated contours and dose information, were imported into ArcherQA. Using a cycle-consistent generative adversarial network (cycle-GAN) trained on an independent dataset, sCT images (sCT1, sCT4, sCT4*) were generated from weekly CBCT scans (CBCT1, CBCT4, CBCT4) paired with corresponding planning CTs (pCT1, pCT1, pCT2). Auto-segmentation was performed on sCTs, followed by GPU-accelerated Monte Carlo dose recalculation. Auto-segmentation accuracy was assessed via Dice similarity coefficient (DSC) and 95th percentile Hausdorff distance (HD95). Dose calculation fidelity on sCTs was evaluated using dose-volume parameters. Dosimetric consistency between recalculated sCT and pCT plans was analyzed via Spearman's correlation, while volumetric changes were concurrently evaluated to quantify anatomical variations. RESULTS: Most anatomical structures demonstrated high pCT-sCT agreement, with mean values of DSC > 0.85 and HD95 < 5.10 mm. Notable exceptions included the primary Gross Tumor Volume (GTVp) in the pCT2-sCT4 comparison (DSC: 0.75, HD95: 6.03 mm), involved lymph node (GTVn) showing lower agreement (DSC: 0.43, HD95: 16.42 mm), and submandibular glands with moderate agreement (DSC: 0.64-0.73, HD95: 4.45-5.66 mm). Dosimetric analysis revealed the largest mean differences in GTVn D99: -1.44 Gy (95% CI: [-3.01, 0.13] Gy) and right parotid mean dose: -1.94 Gy (95% CI: [-3.33, -0.55] Gy, p < 0.05). Anatomical variations, quantified via sCTs measurements, correlated significantly with offline adaptive plan adjustments in ART. This correlation was strong for parotid glands (ρ > 0.72, p < 0.001), a result that aligned with sCT-derived dose discrepancy analysis (ρ > 0.57, p < 0.05). CONCLUSION: The proposed method exhibited minor variations in volumetric and dosimetric parameters compared to prior treatment data, suggesting potential efficiency improvements for ART in NPC through reduced human dependency.
引用
- Lei W, Han L, Cao Z, et al. Nasopharyngeal cancer adaptive radiotherapy with CBCT-derived synthetic CT: deep learning-based auto-segmentation precision and dose calculation consistency on a C-Arm linac. Radiat Oncol. 2025. PMID: 40877957. doi:10.1186/s13014-025-02715-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。